OTC MARKET NEWS Powered By Quantifi

The US vs Mifid II: A regulation clash 

May 15, 2017

Sanford Bragg, IR Magazine

Global asset managers implementing Mifid II research inducement provisions face major challenge in their divergence from US regulatory practices.

A number of areas are set to cause contention as the upcoming pan-European regulation, Mifid II, comes into play. One major flashpoint is the treatment of corporate access, which has become more problematic as EU regulators are favoring the UK’s more stringent interpretations of the rules.

In its April Q&A relating to research inducements, the European Securities and Markets Authority (Esma) clarified its position on corporate access payments, largely in favor of the UK’s stricter view.

Read more

Comments are closed on this post.


Submit your email to receive our newsletter